Scale -


  • Revenue is 16.98 Rs Cr; Annual Growth is 26 %; 5 Year CAGR is 18 %
  • Ebitda is 0.12 Rs Cr; Annual Growth is 107 %; in Bottom Quartile
  • PBT is 0.15 Rs Cr; Annual Growth is 100 %
  • PAT is 0.94 Rs Cr; Annual Growth is 154 %
  • Quarterly Ebitda is 0.05 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is 0.75 %; Annual Growth is 106 %; in Bottom Quartile
  • PAT Margin is 5.54 %; Annual Growth is 143 %
  • Quarterly Ebitda Margin is 1 %; in Bottom Quartile

Return -


  • ROCE is 0.09 %; Annual Growth is 101 %; Continuous Growth over 3 years; in Bottom Quartile
  • ROA is 4.5 %; Annual Growth is 153 %; Continuous Growth over 3 years
  • ROE is 21.67 %; Annual Growth is 142 %; in Top Quartile

Efficiency -


  • Operating cash flow is 0.11 Rs Cr; Annual Growth is 120 %; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 1.65; Continuous Growth over 3 years; in Bottom Quartile
  • Current Ratio is 1.13; Annual Decline is -40 %; Continuous Decline over 3 years; in Bottom Quartile
  • Quick Ratio is 0.47; Annual Decline is -37 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -21 %

Solvancy -


  • Debt/Equity is 0; in Bottom Quartile
  • Long term Debt is 0 Rs Cr; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 92 %; Annual Growth is 3198 %
  • Operating cashflow/PAT is 12 %; Annual Growth is 507 %
  • Change in Inventories/Total Expenses is 2 %; Annual Growth is 108 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Brawn Biotech Limited Estimates – BSE:BRAWN